Article Details

RedHill Biopharma Announces $1.25 Million Registered Direct Offering at a Premium to Market Price

Retrieved on: 2024-04-02 18:23:43

Tags for this article:

Click the tags to see associated articles and topics

RedHill Biopharma Announces $1.25 Million Registered Direct Offering at a Premium to Market Price. View article details on HISWAI: https://www.prnewswire.com/news-releases/redhill-biopharma-announces-1-25-million-registered-direct-offering-at-a-premium-to-market-price-302105607.html

Excerpt

PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up